Characteristic | <95% adherence | ≥95% adherence | OR1 | 95% CI2 | pvalue |
---|---|---|---|---|---|
301 (43.5) n (%) | 392 (56.6) n (%) | ||||
Age | |||||
Median (IQR) | 40 (34 – 45) | 43 (36 – 48) | 1.05 | 1.02 – 1.06 | <0.001 |
Gender | |||||
Male | 195 (64.8) | 284 (72.6) | 1.00 | ||
Female | 106 (35.2) | 107 (27.5) | 0.69 | 0.50 – 0.96 | 0.027 |
Caucasian ancestry | |||||
No | 143 (47.5) | 140 (35.8) | 1.00 | ||
Yes | 158 (52.5) | 251 (64.2) | 1.62 | 1.19 – 2.20 | 0.002 |
Heroin injection3 | |||||
No | 141 (47.0) | 211 (54.1) | 1.00 | ||
Yes | 159 (53.0) | 179 (45.9) | 0.75 | 0.56 – 1.02 | 0.064 |
Cocaine injection3 | |||||
No | 126 (41.9) | 178 (45.5) | 1.00 | ||
Yes | 175 (58.1) | 213 (54.5) | 0.86 | 0.64 – 1.17 | 0.336 |
Amphetamine injection3 | |||||
No | 271 (90.0) | 337 (86.2) | 1.00 | ||
Yes | 30 (10.0) | 54 (13.8) | 1.45 | 0.90 – 2.33 | 0.125 |
Crack cocaine smoking3 | |||||
No | 107 (35.5) | 134 (34.2) | 1.00 | ||
Yes | 194 (64.5) | 257 (65.7) | 1.06 | 0.77 – 1.45 | 0.727 |
MMT3 | |||||
No | 202 (67.1) | 210 (53.7) | 1.00 | ||
Yes | 99 (32.9) | 181 (46.3) | 1.76 | 1.29 – 2.40 | <0.001 |
Time since ART initiation (per year) | 5.1 (2.5 – 8.9) | 6.5 (3.1 – 11.4) | 0.94 | 0.91 – 0.97 | <0.001 |
Median (IQR) | |||||
CD4+ cells at ART initiation | |||||
Median (IQR) | 260 (150 – 390) | 220 (140 – 360) | 1.00 | 1.00 – 1.00 | 0.074 |